These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39091501)

  • 1. Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma.
    Zhu Z; Li X; Yuan X; Chen X; Lin T; Guo X; Li N
    Front Immunol; 2024; 15():1439253. PubMed ID: 39091501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation.
    Xia W; Ma CK; Reid C; Bai L; Wong K; Kerridge I; Ward C; Greenwood M
    J Clin Apher; 2014 Dec; 29(6):322-30. PubMed ID: 24944079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Efficacy of Stem Cell Mobilization With Etoposide+Cytarabine Plus G-CSF in Patients With Multiple Myeloma.
    Zhu Z; Li X; Liu Y; Chen P; Chen X; Li H; Huang J; Chen Y; Li N
    Front Oncol; 2022; 12():825550. PubMed ID: 35155259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study.
    Koyama D; Nishiwaki S; Harada Y; Yamamoto S; Kurahashi S; Sugimoto T; Iwasaki T; Sugiura I
    Jpn J Clin Oncol; 2017 Sep; 47(9):820-825. PubMed ID: 28541555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
    Giebel S; Sadus-Wojciechowska M; Halaburda K; Drozd-Sokolowska J; Wierzbowska A; Najda J; Mendrek W; Sobczyk-Kruszelnicka M; Nowicki M; Holowiecki J; Czerw T
    Ann Hematol; 2016 Jan; 95(2):263-9. PubMed ID: 26611854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood stem cells mobilization in patients with relapsed or refractory lymphomas: A single-center experience.
    Halacoglu A; Serefhanoglu S
    J Cancer Res Ther; 2024 Apr; 20(3):904-908. PubMed ID: 38102912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure.
    Calderón-Cabrera C; Carmona González M; Martín J; Ríos Herranz E; Noguerol P; De la Cruz F; Carrillo E; Falantes JF; Parody R; Espigado I; Pérez-Simón JA
    Transfusion; 2015 Apr; 55(4):875-9. PubMed ID: 25354577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemomobilization with high-dose etoposide and G-CSF results in effective and safe stem cell collection in heavily pretreated lymphoma patients: report from a single institution study and review.
    Ozkan HA; Bal C; Gulbas Z
    Eur J Haematol; 2014; 92(5):390-7. PubMed ID: 24400988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation.
    Jeon SY; Yhim HY; Kim HS; Kim JA; Yang DH; Kwak JY
    Korean J Intern Med; 2018 Nov; 33(6):1169-1181. PubMed ID: 29295612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma.
    Lisenko K; Cremer M; Schwarzbich MA; Kriegsmann M; Ho AD; Witzens-Harig M; Wuchter P
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1397-1402. PubMed ID: 27060439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.
    Lee JL; Kim S; Kim SW; Kim EK; Kim SB; Kang YK; Lee J; Kim MW; Park CJ; Chi HS; Huh J; Kim SH; Suh C
    Bone Marrow Transplant; 2005 Mar; 35(5):449-54. PubMed ID: 15654353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis.
    Dill V; Blüm P; Lindemann A; Biederstädt A; Högner M; Götze KS; Bassermann F; Hildebrandt M
    Transfusion; 2024 May; 64(5):871-880. PubMed ID: 38600674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide.
    McQuaker IG; Haynes AP; Stainer C; Anderson S; Russell NH
    Br J Haematol; 1997 Jul; 98(1):228-33. PubMed ID: 9233591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study.
    Ye P; Cheng Y; Lian J; Tong H; Li L; Guo Q; Zhu W; Feng W; Huang L; Shou L; Chen D; Liu X; Li S; Du X; Yang M; Yu W; Qian J; Hu C; Wang H; Jin Y; Shen J; Hong P; Pei R; Jin J; Lu Y
    Br J Haematol; 2024 Jun; 204(6):2342-2350. PubMed ID: 38400570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
    Kröger N; Zeller W; Fehse N; Hassan HT; Krüger W; Gutensohn K; Lölliger C; Zander AR
    Br J Haematol; 1998 Sep; 102(4):1101-6. PubMed ID: 9734664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
    Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
    Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience.
    Kosmas C; Athanasopoulos A; Dimitriadis G; Miltiadous C; Zilakos M; Lydakis D; Magiorkinis E; Gekas C; Daladimos T; Mylonakis N; Ziras N
    Anticancer Drugs; 2014 Aug; 25(7):841-7. PubMed ID: 24625457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma.
    Xin X; Lin L; Yang Y; Wang N; Wang J; Xu J; Wei J; Huang L; Zheng M; Xiao Y; Meng F; Cao Y; Zhu X; Zhang Y
    Cytotherapy; 2024 May; 26(5):456-465. PubMed ID: 38385909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.
    Aurlien E; Holte H; Kvaløy S; Jakobsen E; Rusten LS; Kvalheim G
    Eur J Haematol Suppl; 2001 Jul; 64():14-20. PubMed ID: 11486395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.